Masoom Haider, MD, provides an overview of the current state of multiparametric MRI, especially in the setting of biopsy-naive patients with elevated PSA levels. He then describes an MRI-directed biopsy pathway and how to integrate it into prostate cancer care.Read More
Masoom Haider, MD
University of Toronto
Toronto, Ontario, Canada
Masoom Haider, MD, received his MD from the University of Ottawa and undertook additional training at the University of Toronto and Cleveland Clinic Foundation. Dr. Haider focuses on prostate cancer localization with MRI using multiparametric approaches; radiological pathologic correlation in prostate cancer, GU malignancies and other abdominal and pelvic malignancies; and feature analysis of tumors for imaging biomarker validation and therapy response assessment. He has worked on establishing guidelines for the use of mpMRI for prostate cancer, including the PI-RADS standard for performance and interpretation of prostate mpMRI. Dr. Haider holds three patents on medical imaging technologies and has over 180 publications in peer-reviewed journals.